Yes-associated protein (YAP) in pancreatic cancer: at the epicenter of a targetable signaling network associated with patient survival

Pancreatic ductal adenocarcinoma (PDAC) is generally a fatal disease with no efficacious treatment modalities. Elucidation of signaling mechanisms that will lead to the identification of novel targets for therapy and chemoprevention is urgently needed. Here, we review the role of Yes-associated prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Rozengurt, Enrique, Sinnett-Smith, James, Eibl, Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908807/
https://www.ncbi.nlm.nih.gov/pubmed/29682330
http://dx.doi.org/10.1038/s41392-017-0005-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908807/
https://www.ncbi.nlm.nih.gov/pubmed/29682330
http://dx.doi.org/10.1038/s41392-017-0005-2

Ejemplares similares